For research use only. Not for therapeutic Use.
Beta-L-D4A(Cat No.: I020361) is a nucleoside inhibitor specifically targeting HIV-1 reverse transcriptase. As a nucleoside analog, it interferes with the replication of the human immunodeficiency virus (HIV) by inhibiting the action of the viral enzyme reverse transcriptase. This enzyme is essential for the conversion of viral RNA into DNA, a crucial step in the HIV life cycle. By disrupting this process, beta-L-D4A helps to prevent the virus from replicating and spreading within the host’s cells.
Catalog Number | I020361 |
CAS Number | 7057-48-9 |
Molecular Formula | C₁₀H₁₁N₅O₂ |
Purity | ≥95% |
IUPAC Name | [(2S,5R)-5-(6-aminopurin-9-yl)-2,5-dihydrofuran-2-yl]methanol |
InChI | InChI=1S/C10H11N5O2/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(3-16)17-7/h1-2,4-7,16H,3H2,(H2,11,12,13)/t6-,7+/m0/s1 |
InChIKey | JFUOUIPRAAGUGF-NKWVEPMBSA-N |
SMILES | C1=C[C@@H](O[C@@H]1CO)N2C=NC3=C(N=CN=C32)N |